Circulating Epstein‐Barr virus microRNAs BART7‐3p and BART13‐3p as novel biomarkers in nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Circulating Epstein‐Barr virus microRNAs BART7‐3p and BART13‐3p as novel biomarkers in nasopharyngeal carcinoma

Published:2020-04-09 Issue:5 Volume:111 Page:1711-1723
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Lu Tianzhu¹²^ORCID,Guo Qiaojuan²,Lin Keyu³,Chen Honglin⁴,Chen Yixin⁵,Xu Yuanji²,Lin Cheng²,Su Ying³,Chen Yan⁶,Chen Mengyuan⁵,Zheng Yuhong⁶,Ye Yunbin⁷,Lin Shaojun²,Zong Jingfeng²,Pan Jianji¹²^ORCID

Affiliation:

1. The School of Clinical Medicine Fujian Medical University Fuzhou China

2. Department of Radiation Oncology Fujian Cancer Hospital Fujian Medical University Cancer Hospital Fuzhou China

3. Department of Radiation Biology Fujian Cancer Hospital Fujian Medical University Cancer Hospital Fuzhou China

4. State Key Laboratory for Emerging Infectious Diseases Department of Microbiology and the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases The University of Hong Kong Hong Kong China

5. National Institute of Diagnostics and Vaccine Development in Infectious Diseases School of Life Sciences Xiamen University Xiamen China

6. Department of Clinical Laboratory Fujian Cancer Hospital Fujian Medical University Cancer Hospital Fuzhou China

7. Laboratory of Immuno‐Oncology Fujian Cancer Hospital Fujian Medical University Cancer Hospital Fuzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14381

Reference35 articles.

1. Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective

2. Nasopharyngeal carcinoma

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

4. Nasopharyngeal carcinoma: Current management, future directions and dental implications

5. Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Epstein-Barr virus microRNA BART8-3p as a potential biomarker for detection and prognostic prediction in early nasopharyngeal carcinoma;Scientific Reports;2024-03-28

2. Impact of plasma Epstein–Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection;Infectious Agents and Cancer;2024-03-14

3. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook;Cancer and Metastasis Reviews;2024-03-02

4. Development of microRNA as diagnostic markers in head and neck cancer;Diagnostic, Prognostic, and Therapeutic Role of MicroRNAs in Head and Neck Cancer;2024

5. Rapid and sensitive detection of Epstein-Barr virus antibodies in nasopharyngeal carcinoma by chemiluminescence strips based on iron-porphyrin single atom nanozyme;Nano Research;2023-07-26